INTERPRETING HIV SERODIAGNOSTIC TEST-RESULTS IN THE 1990S - SOCIAL RISKS OF HIV VACCINE STUDIES IN UNINFECTED VOLUNTEERS

被引:32
作者
BELSHE, RB
CLEMENTS, ML
KEEFER, MC
GRAHAM, BS
COREY, L
SPOSTO, R
WESCOTT, S
LAWRENCE, D
GORSE, GJ
KENNEDY, D
FREY, S
LAMBERT, J
SCHWARTZ, D
DOLIN, R
ROBERTS, N
MCELRATH, J
COOMBS, J
WRIGHT, P
KARZON, D
FAST, P
WALKER, MC
MESTECKY, J
JACKSON, S
STABLEIN, D
WOLFF, M
机构
[1] JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, DEPT INT HLTH, BALTIMORE, MD 21205 USA
[2] UNIV ROCHESTER, SCH MED & DENT, DEPT MED, ROCHESTER, NY 14642 USA
[3] VANDERBILT UNIV, SCH MED, MED CTR N, DEPT MED, NASHVILLE, TN 37232 USA
[4] UNIV WASHINGTON, SCH MED, PACIFIC MED CTR AVEU, DEPT LAB MED, SEATTLE, WA 98144 USA
[5] EMMES CORP, POTOMAC, MD 20854 USA
[6] NIAID, DIV AIDS, BETHESDA, MD 20892 USA
[7] UNIV ALABAMA, BIRMINGHAM, AL USA
关键词
HUMAN IMMUNODEFICIENCY VIRUS; SERODIAGNOSIS; AIDS VACCINES; HIV SEROPOSITIVITY; PREJUDICE;
D O I
10.7326/0003-4819-121-8-199410150-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To evaluate the influence of a human immunodeficiency virus (HIV) vaccine given to uninfected volunteers on the interpretation of serodiagnostic HIV test results. Design: Retrospective cohort study. Setting: 5 AIDS Vaccine Evaluation Units funded by the National Institute of Allergy and Infectious Diseases. Participants: The first 266 healthy adult volunteers (aged 18 to 60 years) who did not have HIV infection and whose history suggested that they were at low risk for acquiring HIV infection. Measurements: HIV antibody was measured by enzyme-linked immunosorbent assay (ELISA) and Western blot test, the results of which were interpreted on the basis of four different published criteria. Results: At some time during the first 12 months of the vaccine studies, 68% of volunteers were positive for HIV antibodies by ELISA. Depending on criteria used to interpret Western blot test results, 0% to 44% of volunteers had positive results that might have caused them to be incorrectly labeled as HIV infected. Conclusions: Significant social risks to volunteers participating in HIV vaccine studies were identified. Persons interpreting HIV serodiagnostic test results must consider that an HIV vaccine can cause a positive result in persons who are not infected.
引用
收藏
页码:584 / +
页数:1
相关论文
共 13 条
  • [1] SAFETY AND IMMUNOGENICITY OF A FULLY GLYCOSYLATED RECOMBINANT GP160 HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VACCINE IN SUBJECTS AT LOW-RISK OF INFECTION
    BELSHE, RB
    CLEMENTS, ML
    DOLIN, R
    GRAHAM, BS
    MCELRATH, J
    GORSE, GJ
    SCHWARTZ, D
    KEEFER, MC
    WRIGHT, P
    COREY, L
    BOLOGNESI, DP
    MATTHEWS, TJ
    STABLEIN, DM
    OBRIEN, FS
    EIBL, M
    DORNER, F
    KOFF, W
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (06) : 1387 - 1395
  • [2] RESOLUTION OF INDETERMINATE HIV-1 TEST DATA USING THE DEPARTMENT-OF-DEFENSE HIV-1 TESTING PROGRAM
    DAMATO, JJ
    OBRYEN, BN
    FULLER, SA
    ROBERTS, CR
    REDFIELD, RR
    BURKE, DS
    [J]. LABORATORY MEDICINE, 1991, 22 (02) : 107 - 113
  • [3] THE SAFETY AND IMMUNOGENICITY OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RECOMBINANT GP160 CANDIDATE VACCINE IN HUMANS
    DOLIN, R
    GRAHAM, BS
    GREENBERG, SB
    TACKET, CO
    BELSHE, RB
    MIDTHUN, K
    CLEMENTS, ML
    GORSE, GJ
    HORGAN, BW
    ATMAR, RL
    KARZON, DT
    BONNEZ, W
    FERNIE, BF
    MONTEFIORI, DC
    STABLEIN, DM
    SMITH, GE
    KOFF, WC
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 114 (02) : 119 - 127
  • [4] DOLIN R, 1992, 8TH INT C AIDS 3RD S
  • [5] VACCINATION OF VACCINIA-NAIVE ADULTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP160 RECOMBINANT VACCINIA VIRUS IN A BLINDED, CONTROLLED, RANDOMIZED CLINICAL-TRIAL
    GRAHAM, BS
    BELSHE, RB
    CLEMENTS, ML
    DOLIN, R
    COREY, L
    WRIGHT, PF
    GORSE, GJ
    MIDTHUN, K
    KEEFER, MC
    ROBERTS, NJ
    SCHWARTZ, DH
    AGOSTI, JM
    FERNIE, BF
    STABLEIN, DM
    MONTEFIORI, DC
    LAMBERT, JS
    HU, SL
    ESTERLITZ, JR
    LAWRENCE, DN
    KOFF, WC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (02) : 244 - 252
  • [6] AUGMENTATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEUTRALIZING ANTIBODY BY PRIMING WITH GP160 RECOMBINANT VACCINIA AND BOOSTING WITH RGP160 IN VACCINIA-NAIVE ADULTS
    GRAHAM, BS
    MATTHEWS, TJ
    BELSHE, RB
    CLEMENTS, ML
    DOLIN, R
    WRIGHT, PF
    GORSE, GJ
    SCHWARTZ, DH
    KEEFER, MC
    BOLOGNESI, DP
    COREY, L
    STABLEIN, DM
    ESTERLITZ, JR
    HU, SL
    SMITH, GE
    FAST, PE
    KOFF, WC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (03) : 533 - 537
  • [7] ABSENCE OF HIV INFECTION IN BLOOD-DONORS WITH INDETERMINATE WESTERN BLOT TESTS FOR ANTIBODY TO HIV-1
    JACKSON, JB
    MACDONALD, KL
    CADWELL, J
    SULLIVAN, C
    KLINE, WE
    HANSON, M
    SANNERUD, KJ
    STRAMER, SL
    FILDES, NJ
    KWOK, SY
    SNINSKY, JJ
    BOWMAN, RJ
    POLESKY, HF
    BALFOUR, HH
    OSTERHOLM, MT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (04) : 217 - 222
  • [8] FREQUENCY OF INDETERMINATE WESTERN-BLOT TESTS IN HEALTHY-ADULTS AT LOW-RISK FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    MIDTHUN, K
    GARRISON, L
    CLEMENTS, ML
    FARZADEGAN, H
    FERNIE, B
    QUINN, T
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (06) : 1379 - 1382
  • [9] DIFFERENCES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ANTI-P24 REACTIVITIES IN SERUM OF HIV-1-INFECTED AND UNINFECTED SUBJECTS - ANALYSIS OF INDETERMINATE WESTERN-BLOT REACTIONS
    POVOLOTSKY, J
    GOLD, JWM
    CHEIN, N
    BARON, P
    ARMSTRONG, D
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (02) : 247 - 251
  • [10] OCCURRENCE, CHARACTERISTICS, AND PATTERNS OF HIV-1 AND HIV-2 WESTERN-BLOT INDETERMINATE SERA IN LOW-RISK POPULATIONS IN WEST-VIRGINIA AND PRE-AIDS AFRICA
    SCHINDZIELORZ, AH
    BELSHE, RB
    MUFSON, MA
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1990, 42 (05) : 460 - 464